EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial.

H. Cheng, K. Ballman, M. Vassilakopoulou, A. C. Dueck, M. M. Reinholz, K. Tenner, J. Gralow, C. Hudis, N. E. Davidson, G. Fountzilas, A. E. McCullough, B. Chen, A. Psyrri, D. L. Rimm, E. A. Perez

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint Dive into the research topics of 'EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial.'. Together they form a unique fingerprint.

Medicine & Life Sciences